1999
DOI: 10.1016/s1074-5521(99)80093-3
|View full text |Cite
|
Sign up to set email alerts
|

Computational drug design

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…In an early stage of the drug discovery process, the focus is on reducing the number of drug candidates and this problem has been deciphered using computational approaches. 2 A drug is a small molecule which activates or inhibits the function of protein, as proteins are one of the popular targets for the drug designing process. 3 The interaction between a protein and ligand is specific.…”
Section: Introductionmentioning
confidence: 99%
“…In an early stage of the drug discovery process, the focus is on reducing the number of drug candidates and this problem has been deciphered using computational approaches. 2 A drug is a small molecule which activates or inhibits the function of protein, as proteins are one of the popular targets for the drug designing process. 3 The interaction between a protein and ligand is specific.…”
Section: Introductionmentioning
confidence: 99%
“…Before choosing the protein, the activities of the specific ligand were investigated, and the strong activities were taken into consideration. For the interaction, the protein was received in PDB format from the RCBS protein library, , as shown in Figure B,D. With the help of AutodockVina and Chimera, the titled molecule is studied further for biological activity.…”
Section: Resultsmentioning
confidence: 99%
“…In this paper, we have advanced a new hypothesis that reprogramming of tumor cells can be achieved by avoiding toxic chemotherapy and instead by using a completely different set of pharmacological agents, in particular psychoactive compounds. Their repurposing can be achieved by rational drug design [101] involving derivatization that should take into account the molecular structure of the target and such aspects as blood-brain-barrier permeation.…”
Section: Resultsmentioning
confidence: 99%